Final Agenda

8:30 a.m. to 9:00 a.m.

Welcome and Introduction/Breakfast

Nancy Donley
President
S.T.O.P. - Safe Tables Our Priority
Mother of Alex, 1987-1993

 

9:00 a.m. to 10:15 a.m.

The Basis of the Acute Phase of Verotoxin-Induced HUS: Molecular Risk Factors

Clifford A. Lingwood, Ph.D.
Senior Scientist
Research Institute
Section of Infection, Immunity, Injury and Repair
The Hospital for Sick Children
Professor
Departments of Laboratory Medicine & Pathobiology and Biochemistry
University of Toronto Toronto, Ontario

 

10:15 to 11:00 a.m.

Plasma Exchange in the Treatment of TTP/HUS with Long Term Follow Up and Prognosis

Gail Rock, Ph.D., M.D., FRCP
Chief
Division of Hematology & Transfusion Medicine
Department of Pathology & Laboratory Medicine
Ottawa Hospital
Professor, Department of Pathology and Laboratory Medicine
Faculty of Medicine
University of Ottawa
Ottawa, Ontario

 

11:00 a.m. to 11:15 Question and Answer Period

11:15 a.m. to 11:30 a.m. Break

11:30 a.m. to 12:00 noon

Escherichia coli O157:H7 of the GI Tract: Complications Beyond Diarrhea

Phillip I. Tarr M.D.
Attending Gastroenterologist
Children's Hospital & Regional Medical Center
Professor;
Pediatrics, Division of Gastroenterology
University of Washington
Seattle, Washington

 

12:00 noon to 12:30 p.m.

Diabetes and HUS

Richard S. Mauseth M.D.
Board Certified Pediatric Endocrinologist
Woodinville Pediatrics
Woodinville, Washington

 

12:30 p.m. to 12:45 p.m. Question and Answer Period

12:45 to 1:45 p.m. Lunch

1:45 to 2:45 p.m.

Long Term Renal Outcomes in Diarrhea-Associated HUS

John Brandt, M.D., M.P.H.
Assistant Professor of Pediatrics
University of New Mexico School of Medicine
Albuquerque, New Mexico

 

2:45 to 3:15 p.m.

Long-Term Consequences of HUS: the ENCHLOSE network (ENCHLOSE: European Network for Childhood HUS Longterm Sequelae)

Piero Ruggenenti M.D.
Assistant-Professor
Division of Nephrology and Dialysis
Ospedali Riuniti di Bergamo, Italy
Chairman
Department of Renal Medicine
Clinical Research Center
'Mario Negri' Institute for Pharmacological Research
Bergamo, Italy

 

3:15 to 3:30 p.m. Question and Answer Period

3:30 to 3:45 p.m. Break

3:45 p.m. to 4:30 p.m.

HUS: The 'eart of the Problem

Garry Cornel MB, BS, FRCS(C)
Chief, Division Cardiovascular Surgery
Children's Hospital of Eastern Ontario Associate Professor of Surgery
University of Ottawa
Ottawa, Ontario

 

4:30 to 5:15 p.m.

Neuropsychological Sequelae of HUS: A Positive Outcome

Elaine Orrbine
Director,
Child & Youth Clinical Trials Network
Children's Hospital of Eastern Ontario Research Institute
Lecturer,
Department of Pediatrics
University of Ottawa
Ottawa, Ontario

 

5:15 p.m. to 5:30 p.m. Question and Answer Period

 




Copyright 2000 | Reprint Policy 
Last Modified: September 1, 2001